Rebirth 1975: Tore up the call-back order at the beginning

Chapter 661: Progress of the Sickle Project!

Hong Kong Island. Kowloon!

On a high-rise office building on Jordan Road, a far-reaching negotiation is in full swing.

The identities of the negotiating parties are very different. One is Hong Kong Island Yuanwei Pharmaceutical, a small company that has just been established for a short time, and the other is the most powerful pharmaceutical company in China——Johnson & Johnson Biological Group.

And the content of their negotiations is about the patent authorization of fluoxetine!

The negotiations have been going on for more than two hours, but on the core issues, the two sides have never been able to reach an agreement.

"Mr. Yan, if you think the price of 1800 million US dollars is lower than expected, we can add another 200 million. How about 2000 million?"

In the main seat on the left, Yan Gengdong said calmly: "Mr. Polk, you know, it's not about money!"

"what is that?"

"Mr. Polk, let me reiterate our company's point of view. We will not sell the patent on fluoxetine. If your company wants to cooperate with us, please dispel this idea."

"Mr. Yan, 2000 million US dollars is already a lot, and it can buy several small companies like yours, isn't it!"

"Hehe, if the company doesn't have a good product, it really won't be worth much, but Yuanwei Pharmaceutical is obviously not such a company, so please put away your sense of superiority!" Yan Gengdong said.

Polk frowned and said, "Mr. Yan, you should be aware of the strength of Johnson & Johnson. Without our nod, it is impossible for your drug to pass the review and enter the North American market!"

Yan Gengdong smiled and said: "I have never doubted the strength of your company, but if this is the sincerity of your company's cooperation, then please come back!"

"Mr. Yan, do you really want to reject our Johnson & Johnson Group?" Polk stared at Yan Gengdong and asked.

"It's not that I want to reject your company, but that your company has no sincerity to cooperate!"

Then Yan Gengdong said mockingly: "You want to buy out the patent rights of fluoxetine in North America for 2000 million US dollars. Your company is not cooperating with us at all, but joking with us!"

"Mr. Yan, as far as I know, the market performance of your drug in Hong Kong Island is not very good. If you insist on developing it yourself, you may not be able to earn 2000 million US dollars." Polk said.

Yan Gengdong glanced at him and said lightly: "Mr. Polk, where did you hear that the market performance of fluoxetine is not good? Do you know the sales volume of fluoxetine in Asia last month?"

"This...is not very clear!"

Yan Gengdong glanced at the sales executive next to him, and then said: "Manager Xiao, tell Mr. Pok about our company's sales performance last month!"

Xiao Wenyuan immediately said: "Mr. Polk, the local (Hong Kong Island) sales team won a total of 167 million US dollars in sales last month, the Bay Island team won 188 million, the Australia Island team won 59, and the South Korean side 289 million. 582 million from Little Days, plus the Southeast Asian market that is being developed, our company’s revenue reached 1280 million last month!"

Hearing Xiao Wenyuan's words, Polk was stunned.

The negotiation between them and Yuanwei Medicine has been going on for more than half a month, and they have already investigated the situation of this company.

The company was established only half a year ago. Although the company's self-developed fluoxetine has good curative effects in the treatment of depression and anorexia nervosa, it has not been tested by the market. Therefore, whether this drug can be used Market acceptance is still an unknown.

It is precisely because of this that they will offer a price of 2000 million US dollars and want to buy out the patent authorization of the drug in North America.

However, they did not expect that the market performance of this drug would be so good. In Asia alone, the monthly revenue reached more than 1000 million US dollars.

Judging by the profits of the pharmaceutical industry, the drug brought more than 800 million net profits to this small company in the last month alone. No wonder the other party is so determined!

More importantly, the market response to this drug is so good now, it can be expected that the profits will only increase in the future.

At that time, other domestic pharmaceutical companies may also be interested in this drug, which made Polk feel a little pressure.

At this time, Yan Gengdong said again: "Mr. Polk, we just reached an agreement with Ruiying Pharmaceuticals in Europe this month to jointly produce and sell fluoxetine. Unexpectedly, fluoxetine will be available in Europe soon."

"As for North America, even if we don't cooperate with your company, we can still enter the North American market. After all, besides Johnson & Johnson, Pfizer and Eli Lilly are also very interested in our drug!"

Polk knew that they had missed the best opportunity to acquire the patent of this drug at a low price, and Plan A failed completely.

Good thing they have a plan B!

At the moment, he immediately adjusted his mood, and then said: "Since Mr. Yan is not willing to sell the patent rights of fluoxetine, we will not force it, but we, Johnson & Johnson, want the exclusive agency rights in North America!"

"This is negotiable, but the annual agency fee cannot be less than 5000 million US dollars, and we also need 20% of the sales profit!" Yan Gengdong said.

"5000 million is too much, we can pay 1500 million at most, and the other 20% of the sales profit has exceeded the normal drug sharing limit, up to 10%!"

"We each take a step back, 4000 million agency fees plus 18% sales share!"

"2000 million, 12%..."

"3500 million, 17%..."

After some bargaining, the two parties finally reached an agreement with an agency fee of 2500 million plus 15% of sales revenue!

After sending Polk away, Yan Gengdong once again met with the representative of Little Days Otsuka Pharmaceutical, and continued to negotiate with the other party on the sales promotion of fluoxetine.

At six o'clock in the evening, after seeing off the last batch of guests, Yan Gengdong returned to his residence on the top floor of the company.

After confirming that the surrounding environment was safe, he took out a small radio from the secret safe and started operating it in the house.

Soon, a top-secret telegram was sent out by him!

After putting away the radio, Yan Gengdong came to the window, looked at the flashing neon lights outside, and silently lit a cigarette.

Counting today, it has been almost four months since he came to Hong Kong Island!

During these four months, he took advantage of the convenient conditions provided by the Ministry of Commerce to quickly take over Weiyuan Pharmaceutical Company.

Don't think that this company was established by people from the Ministry of Commerce, but in order to keep it secret, apart from the staff who formed the company at the beginning, only Yan Gengdong was sent from China.

The rest are ordinary people recruited locally, ranging from managers and supervisors of the company to receptionists, clerks and even cleaning staff.

No way, if people know that this company has a background in the mainland, it will not be easy to do business with Western countries.

Even in order to prevent others from doubting his identity, when Yan Gengdong entered Hong Kong Island, he bought Weiyuan Company through Siam as a Thai Chinese.

After taking over the company, Yan Gengdong promoted fluoxetine in an all-round way according to the promotion plan given to him by Zhou Yang.

In the first month, the company only conducted business on Hong Kong Island, and its revenue was less than 50 Hong Kong dollars.

In the second month, the business expanded to the surrounding Bay Island and Ao Island, and the revenue increased to 300 million Hong Kong dollars.

In the third month, fluoxetine was recognized by patients due to its good efficacy and reliable properties, and its reputation soared. He took this opportunity to send a team to cooperate with pharmaceutical companies in South Korea, Xiaori and other countries, and his turnover skyrocketed.

Right now, the company has created a profit of nearly ten million US dollars. In addition to signing and cooperation agreements with Johnson & Johnson Group and Otsuka Pharmaceuticals today, it has once again received nearly 3000 million US dollars in agency fees.

As a result, the company's profit has exceeded 4000 million US dollars, far exceeding the amount of domestic tasks.

The company's development has been on the right track and has achieved certain results. Yan Gengdong decided to pass this good news back to China!

But what Yan Gengdong didn't know was that after his telegram was sent to China, it quickly caused a sensation among the top management!

PS: Chapter 2 is delivered!

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like